http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2404976-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc0a660b94e5a16da4df469e7951e6f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c90d4c9eb6f4837513dd1a4c6906f811 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 |
| filingDate | 2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d091d90fa24958d7c920f69b17ad532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a575e601380f594212e9e60d0992b6d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6f8fe693a5ca0cd063a49b2d5201523 |
| publicationDate | 2010-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2404976-C1 |
| titleOfInvention | Agent to reduce alcohol addiction, pharmaceutical composition, method for making thereof, medicinal agent and method of treating |
| abstract | FIELD: medicine. ^ SUBSTANCE: invention refers to a new agent to reduce alcohol addiction, representing hydroxy-substituted flavonoids of general formula 1, 1 1.1 1.1 (1), where: R1, R2, R3, and R5 independently represent hydrogen atom or optionally substituted hydroxyl; R4 represents hydrogen atom, hydroxyl, optionally substituted monosaccharide, with the exception of -D-glucopyranosyl and -L-rhamnopyranosyl (6-deoxy- -L-mannopyranosyl), optionally substituted disaccharide; R6 represents hydrogen atom or methyl. Preferentially, the agent represents flavonoid of general formula 1.1 where R1, R2 and R4 have the above-stated value, e.g., such as apigenin - 5,7-dihydroxy-2-(4-hydroxyphenyl)-chromene-4 of formula 1.1(1). Also the agent can represent mixed effective amount of flavonoid of general formula 1, preferentially of formula 1.1, such as apigenin of general formula 1.1(1) and thianine of formula 2 or its pharmaceutically acceptable salt. ^ EFFECT: improved clinical effectiveness. ^ 9 cl, 2 dwg, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116650471-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116650471-B |
| priorityDate | 2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.